CYP19A1 and hepatocellular carcinoma: A study by Carruba et al. [138,139] carried out on nontumoral, cirrhotic, and malignant human liver tissue samples (in vivo) and in HepG2, HuH7, and HA22T cells (in vitro) revealed for the first time that the level of the aromatase enzyme is significantly increased in liver cancer cells (malignant human liver tissue and HepG2 hepatoma cells), which leads to an increase in the local conversion of estrogens from androgens.